Ensemble Health Partners Awarded Tenth U.S. Patent for Latest Innovative Technology, Driving Frictionless Revenue Cycle Management for Healthcare Providers
May 15, 2024 16:00 ET
|
Ensemble Health Partners
Cincinnati, OH, May 15, 2024 (GLOBE NEWSWIRE) -- Ensemble Health Partners (Ensemble), the market leader in end-to-end revenue cycle outsourcing for mid-sized to large healthcare organizations,...
SaverOne Granted New European Patent Strengthening its 23 Patent IP Portfolio in Multi-Billion Dollar Safety Transportation Market
May 14, 2024 08:30 ET
|
SaverOne 2014 Ltd.
Petah Tikvah, Israel, May 14, 2024 (GLOBE NEWSWIRE) -- SaverOne 2014 Ltd. (Nasdaq: SVRE, TASE: SVRE), a technology company engaged in disruptive transportation safety solutions, is pleased to...
Esperion Receives Five Year Patent Extension for Bempedoic Acid, Contained in NEXLETOL® and NEXLIZET®
May 14, 2024 08:00 ET
|
Esperion Therapeutics, Inc.
ANN ARBOR, Mich., May 14, 2024 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) announced today that the U.S. Patent and Trademark Office (USPTO) issued a U.S. Patent Term Extension (PTE) certificate for...
VelocityEHS Earns 5 AI Patents and Publishes in Nature
May 14, 2024 07:56 ET
|
VelocityEHS
CHICAGO, May 14, 2024 (GLOBE NEWSWIRE) -- VelocityEHS®, the global leader in enterprise EHS & ESG software solutions, has recently been awarded five patents by the U.S. Patent and Trademark...
ElevateBio Announces New U.S. Patents for Lead Life Edit CRISPR Systems and Adenine Deaminases Enabling Advanced Gene Editing Techniques
May 14, 2024 07:00 ET
|
ElevateBio
- Issued patents provide protection for multiple of Life Edit’s lead adenine deaminases, base editors, and RNA-guided nucleases with applications in base editing and reverse transcriptase editing - ...
MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Treatment of Chlorine-Induced Acute Respiratory Distress Syndrome
May 14, 2024 06:00 ET
|
MediciNova, Inc.
LA JOLLA, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange...
Earth Alive Clean Technologies Inc. consolide sa stratégie brevets grâce à son innovation Soil Activator-TG™ et renforce ainsi sa position sur le marché global des biofertilisants
May 13, 2024 10:59 ET
|
Earth Alive Clean Technologies Inc.
MONTRÉAL, 13 mai 2024 (GLOBE NEWSWIRE) -- Earth Alive Clean Technologies Inc. (TSXV: EAC) (« Earth Alive » ou la « Société »), un leader dans le développement, la fabrication et la distribution...
Earth Alive Clean Technologies Inc. Consolidates Patent Strategy with its Soil Activator-TG™ Innovation and Strengthens its Position in the Global Biofertilizer Market
May 13, 2024 10:59 ET
|
Earth Alive Clean Technologies Inc.
MONTREAL, May 13, 2024 (GLOBE NEWSWIRE) -- Earth Alive Clean Technologies Inc. (TSXV: EAC) ("Earth Alive" or the "Company"), a leader in the development, manufacturing, and distribution of advanced...
Clearmind Medicine Advances its Proprietary Psychedelic- Based Synthetic Alcohol Beverage Product
May 10, 2024 08:24 ET
|
Clearmind Medicine Inc.
The global market of no- and low-alcohol beverages estimated at over $13 billion in 2023 Vancouver, Canada, May 10, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0)...
Recce Pharmaceuticals Granted New Patent in China for RECCE® Anti-Infectives
May 08, 2024 08:00 ET
|
Recce Pharmaceuticals
SYDNEY, Australia, May 08, 2024 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd. (ASX: RCE, FSE: R9Q), the Company developing a new class of synthetic anti-infectives, today announced the China...